NIVOLUMAB, BT5528
BT5528-100
Phase 2 small_molecule active
Quick answer
NIVOLUMAB, BT5528 for Advanced Malignancies Associated with EphA2 Expression is a Phase 2 program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BICYCLE THERAPEUTICS
- Indication
- Advanced Malignancies Associated with EphA2 Expression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active